Chemical Structure : CCT241736
CAS No.: 1402709-93-6
货号: PC-24959Not For Human Use, Lab Use Only.
CCT241736 (Mobinitinib) is a potent, orally bioavailable dual FLT3/Aurora kinase inhibitor with binding Kd of 7.5/48/6.2/38/14 nM for Aurora-A/Aurora-B/FLT3 WT/FLT3-ITD/FLT3(D835Y) respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥480 | In stock | |
10 mg | ¥780 | In stock | |
25 mg | ¥1280 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CCT241736 (Mobinitinib) is a potent, orally bioavailable dual FLT3/Aurora kinase inhibitor with binding Kd of 7.5/48/6.2/38/14 nM for Aurora-A/Aurora-B/FLT3 WT/FLT3-ITD/FLT3(D835Y) respectively.
CCT241736 (Mobinitinib) shows S(10) selectivity score of 0.057 in a 442-kinase panel (containing 386 nonmutant kinases) at a concentration of 1 μM using the KINOMEScan technology.
CCT241736 (Mobinitinib) displays antiproliferative activity in a range of human tumor cell lines, including HCT116 human colon carcinoma (GI50 = 0.300 μM) and the human FLT3-ITD positive AML cell lines MOLM-13 (GI50 = 0.104 μM) and MV4–11 (GI50 = 0.291 μM). inhibited both the autophosphorylation of Aurora-A at T288 (a biomarker for Aurora-A inhibition: IC50 = 0.030 μM) and histone H3 phosphorylation at S10 (a biomarker for Aurora-B inhibition: IC50 = 0.148 μM) in HeLa cells.
CCT241736 (Mobinitinib) (50-100 mg/kg po b.i.d.) significantly inhibits the growth of MV4–11 human FLT3-ITD positive AML tumor xenografts in athymic mice.
分子量 | 456.38 | |
分子式 | C22H23Cl2N7 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
6-Chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyridine |
1. Wood FL, et al. Eur J Pharm Sci. 2019 Nov 1;139:104899.
2. Bavetsias V, et al. J Med Chem. 2012 Oct 25;55(20):8721-34.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright